VoxNova
Mission Investor Relations - Targeted Strategies for Today's Evolving MarketsMission Investor Relations | Targeted Strategies fo
Description: We develop innovative treatments for unmet needs in neurodevelopmental disorders affecting millions of children and adults.
PaxFLASH A Promising Path in Autism Learn More New Hope for Families Understand the Impact There are currently no approved pharmacologic treatments for Autism Spectrum Disorder (ASD) that target its cause and symptoms. PaxMedica is on a promising path to change that, bringing hope to millions. PaxMedica is a clinical-stage biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders.
Our lead programs are focused on Autism Spectrum Disorder (ASD).
Autism Spectrum Disorders are characterized by extreme versions of the processes that govern the ability to (1) focus attention, and (2) filter out sensory input. While these often bring with them a wide range of special abilities — including the ability to hyperfocus on specific tasks — they also can make normal everyday interactions and activities more challenging, not only for people with autism, but also for those around them, beginning with their families.
VoxNova
Mission Investor Relations - Targeted Strategies for Today's Evolving MarketsMission Investor Relations | Targeted Strategies fo